Diabetes

A review of 24 meta-analyses supported the need for additional monitoring of patients with diabetes and COVID-19, especially if they have comorbidities associated with diabetes.

Authors offered specific recommendations for improving publishing and adoption of algorithmic processes focused on type 2 diabetes (T2D) going forward.

Knowledge is limited on the potential exclusion from pay-for-performance (P4P) programs of patients living with diabetes who have with individual or neighborhood social risks.

Study authors said the findings could inform clinicians when selecting therapies for patients with type 2 diabetes (T2D). However, an editorial found the follow-up period too short and differences between the study arms too small to be meaningful.

Diabetes risk perception was linked to increased TV watching and 1 less day per week of at least 60 minutes of exercise, and was not associated with nutrition or weight loss attempts among adolescents.

Investigators said data show social factors are intertwined with health outcomes.

Researchers are beginning work on a double-blind randomized controlled trial to test the results of this preliminary study.

The risk of incident diabetes was found to be 17% greater in individuals who had COVID-19, and it was higher among men and individuals with severe COVID-19.

The weight loss surgery may help reverse peripheral neuropathy and improve the stability of cardiovascular autonomic neuropathy and retinopathy in individuals with class II/III obesity.

Banner|Aetna's partnership with Virta and their diabetes reversal program brings to light the possibility for expansion to other health issues.

Researchers developed a reliable prediction model for kidney function decline in adults with type 2 diabetes and early to moderately progressed chronic kidney disease, which was externally validated and made publicly available via a web-based application.

Banner|Aetna has partnered with Virta and their diabetes reversal program, which now has data on outcomes and patient populations served so far.

The 2021 recommendations for diabetes and prediabetes screening led to a 14.8% proportionate increase in the total US population eligible for screening, compared with the 2015 guidelines.

For employers, keeping members engaged with their health care is one of the key factors that leads to better outcomes, said Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana.

An analysis of more than 500,000 pregnancies over a 15-year period suggests much of the increase in gestational diabetes rates observed during the study period can be attributed to changes in screening practices.

New research suggests older adults with both diabetes and edentulism are more likely to experience worse and faster cognitive decline compared with adults without either condition and adults older in age.

The findings of the ACCESS study show the complex challenge of improving medication adherence among the most fragile members of society.

Baxdrostat is a highly selective aldosterone synthase inhibitor; phase 1 studies showed that the therapy caused a sustained, dose-dependent reduction in plasma aldosterone by more than 70% without reducing cortisol.

Deepak L. Bhatt, MD, MPH, Icahn School of Medicine at Mount Sinai, has multiple presentations during the upcoming American College of Cardiology Scientific Sessions, including additional phase 2 results from the ENTRIGUE trial for pegozafermin in severe hypertriglyceridemia. 

Eli Lilly announced it will automatically cap out-of-pocket (OOP) costs at $35 at participating retail pharmacies for Americans with commercial insurance using some of its insulin products.

Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana, explains how the company works with employers to prevent and manage diabetes.

Researchers looked at trends in insulin usage and expenditure among insured and uninsured populations with diabetes, accounting for how the expansion of Medicaid under the Affordable Care Act may have affected these trends.

While there are a number of treatments available for diabetic kidney disease (DKD), the biggest limitation is the lack of early detection, said Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute.

Adjusted analyses showed vitamin D reduced diabetes risk by 15%, with a 3-year absolute risk reduction of 3.3%.

Research showed that a mean of 19.5%, 17.1%, and 43.3% of adults with diabetes did not maintain continuity in use of medications to lower glucose, blood pressure, or lipid levels, respectively.

Treatment strategies for diabetes should include a comprehensive approach involving multidisciplinary care teams.

Treatment strategies for diabetes should include a comprehensive approach involving multidisciplinary care teams.

Adults with diabetes who were forced to switch from an employer-sponsored health plan to a high-deductible health plan (HDHP) were 25% more likely to require an emergency department (ED) or hospital visit for hyperglycemia, but not for hypoglycemia, than those who did not switch plans.

Cardiovascular risk can be significantly impacted by the presence of diabetes.

Experts highlight key factors when considering costs associated with diabetes treatment pathways.